We believe that accurately identifying and articulating the most pressing problems in health and healthcare is the first and most fundamental step in building frontier-advancing, scalable solutions. A meaningful understanding of such needs requires a broad view, one that embraces how questions of science and technology are tied inextricably to economic, policy, and social circumstances and histories.
Here we write on the science, technologies, and policies that underpin our work across public-private partnerships, public interest technologies, and catalytic capital.
Biomedical innovation advances at the speed of scientific progress. And scientific progress is driven by advancements in available tools. For this reason, we’ve been increasingly curious about the systems, structures, financial products and models available to support the creation of research tools.
Notes on Catalyzing Health
Digitalis Commons, the non-profit affiliate of Digitalis Ventures, has entered into a Partnership Intermediary Agreement to provide commercialization services to the Advanced Research Projects Agency for Health’s (ARPA-H) Project Accelerator Transition Office (PATIO). This first-of-its-kind agreement aims to speed up and smooth the process of getting breakthrough innovations in health to the American public.